PSNL
Personalis Inc
NASDAQ: PSNL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$5.04
-8.36% today
Updated 2026-04-29
Market cap
$575.73M
P/E ratio
—
P/S ratio
8.27x
EPS (TTM)
$-0.91
Dividend yield
—
52W range
$4 – $12
Volume
1.6M
Personalis Inc (PSNL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $290000.00 | $5.57M | $-18.07M | $-42.65M | $-70.83M | $-70.23M | $-56.26M | $-45.15M | $-74.95M |
| Capital expenditures | $5.16M | $7.85M | $8.38M | $3.25M | $11.08M | $49.90M | $10.91M | $1.60M | $4.50M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $753000.00 | $1.32M | $4.86M | $8.24M | $14.38M | $19.43M | $14.05M | $10.69M | $9.43M |
| Free cash flow | $-4.87M | $-2.28M | $-26.45M | $-45.90M | $-81.91M | $-120.13M | $-67.17M | $-46.75M | $-79.45M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $13.47M | $38.80M | $-16.33M | — | — | — |